Electrically Stimulating Nerve Regeneration

• US 20060287660A1
• Filed: 06/15/2006
• Published: 12/21/2006
• Est. Priority Date: 06/15/2005
• Status: Abandoned Application

• Current Assignee: Neurosilicon, Co.
• Original Assignee: Neurosilicon, Co.
• Inventors: Jullien, Graham Arnold, Syed, Naweed I.
• Application Number:
  US11/424,413
• Publication Number:
  US 20060287660A1
• Time in Patent Office: Days
• US Class Current: 606/152
• CPC Class Codes: A61B 17/11 for performing anastomosis; Buttons for anastomosis
• CPC Class Codes: A61B 17/1128 of nerves
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61N 1/0456 Specially adapted for transcutaneous electrical nerve stimulation [TENS]
• CPC Class Codes: A61N 1/0464 Specially adapted for promoting tissue growth
• CPC Class Codes: A61N 1/0472 Structure-related aspects
• CPC Class Codes: A61N 1/0476 Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/205 for promoting a biological process
• CPC Class Codes: A61N 1/326 for promoting growth of cells, e.g. bone cells
• CPC Class Codes: A61N 1/37205 Microstimulators, e.g. implantable through a cannula

Abstract

This document pertains generally to the field of nerve regeneration and more particularly to functional recovery after nerve injury or transection. For example, this document provides a silicon chip device coupled with field effect (or other types of) transistors, growth permissive chemical substrates, and trophic molecules that together can enable the rapid and successful regeneration of injured nerves. Such devices can be used to stimulate continually the transected target tissue to create an environment that is highly conducive to growth and reinnervation.

Claims

1. A system for promoting nerve regeneration, wherein said system comprises:

(a) a housing comprising a distal end, a proximal end, and a plurality of segments from said distal end to said proximal end, wherein said housing defines a cavity region for nerve regeneration, and wherein each of said plurality of segments comprises an electrode;

(b) an integrated circuit configured to control at least one of said electrodes;

(c) a pump configured to release an agent into said cavity region; and

(d) a power supply configured to provide power to said integrated circuit, said at least one of said electrodes, or said pump.

2. The system of claim 1, wherein said housing is tubular.

3. The system of claim 1, wherein said housing is tubular with an opening along the length of said housing from said distal end to said proximal end.

4. The system of claim 1, wherein the width of each of said plurality of segments is same.

5. The system of claim 1, wherein each of said plurality of segments comprises multiple electrodes.

6. The system of claim 1, wherein said integrated circuit is attached to said housing.

7. The system of claim 1, wherein said integrated circuit is formed within said housing.

8. The system of claim 1, wherein said system comprises an integrated circuit for each of said plurality of segments.

9. The system of claim 1, wherein said housing is flexible.

10. The system of claim 1, wherein said pump defines a reservoir comprising said agent.

11. The system of claim 1, wherein said each of said plurality of segments comprises at least one of said pumps.

12. The system of claim 1, wherein each of said plurality of segments comprises at least one outlet fluidly connected to said pump.

13. The system of claim 1, wherein said system comprises a reservoir configured to be outside a mammal'"'"'s body, wherein said reservoir is fluidly connected to said pump.

14. The system of claim 1, wherein said housing comprises an orthogonal arrangement of electrodes.

15. The system of claim 1, wherein said housing comprises at least two orthogonal sets of electrodes on different layers so that each set is electrically isolated from each other.

16. The system of claim 1, wherein said system comprises an integrated transistor array.

17. The system of claim 16, wherein said system comprises a microcontroller connected to said integrated transistor array.

18. The system of claim 16, wherein said system comprises a computer configured to be outside a mammal'"'"'s body.

19. The system of claim 16, wherein a surface of said housing adjacent to said cavity region is coated with a substrate adhesion molecule.

20. The system of claim 16, wherein said substrate adhesion molecule is fibronectin, laminin, or collagen.

21. A system for nerve regeneration, said system comprising:

(a) a tubular housing comprising a flexible circuit substrate;

(b) an arrangement of insulated electrode tracks;

(c) one or more integrated circuits for controlling an electrode of said arrangement;

(d) a power source to provide said one or more integrated circuits with sufficient voltage to drive an electrode of said arrangement, thereby forming an electric field within said tubular housing;

(e) an integrated micro-pump for supplying at least one agent to a region within said tubular housing;

(f) an external power source; and

(g) an external microcomputer.

22. The system of claim 21, wherein said one or more integrated circuits comprises an integrated transistor array.

23. The system of claim 21, wherein said one or more integrated circuits comprises a microcontroller.

24. The system of claim 21, wherein said tubular housing or circuit substrate comprises a material that is non-toxic.

25. The system of claim 21, wherein said tubular housing or circuit substrate is coated with a substrate adhesion molecule.

26. The system of claim 25, wherein said substrate adhesion molecule is fibronectin, laminin, or collagen.

27. The system of claim 21, wherein said integrated circuits comprise arrays of a definable number of transistors bonded to the flexible substrate so as to electrically connect to an array of insulated electrode tracks formed on said flexible substrate.

28. The system of claim 21, wherein said integrated circuits comprise a processor and a voltage driver.

29. The system of claim 21, wherein an array of transistors inside said integrated circuits drives a set of tracks in a circular arrangement on the inside of said tubular housing and another set of tracks arranged along the length of said tubular housing.

30. The system of claim 21, wherein said integrated circuits are capable of generating an electrical field via voltages applied to said arrangement of insulated electrode tracks, wherein said arrangement of insulated electrode tracks are fabricated on said flexible circuit substrate to form, cover, or be on the interior of said tubular housing.

31. The system of claim 21, wherein said insulated electrode tracks are on the flexible substrate and are capable of generating electric fields both radially across and along said tubular housing.

32. The system of claim 21, wherein said micro-pump is configured to deliver said agent to said region in a controlled and systematic manner.

33. The system of claim 21, wherein said system comprises a means for supplying said at least one agent.

34. The system of claim 31, wherein said means for supplying said at least one agent comprises nano-beads comprising said at least one agent encapsulated in nano-particles or quantum dots.

35. The system of claim 31, wherein said means for supplying said at least one agent releases said at least one agent when triggered by an electrical field.

36. The system of claim 33, wherein said system is capable of forming an electric field radially across said tubular housing to enable electrophoretic or dielectrophoretic distribution of said at least one agent across a growth cone of a regenerating nerve fiber.

37. The system of claim 31, wherein said means for supplying said at least one agent comprises nano-beads.

38. The system of claim 31, wherein said agent is a trophic factor.

39. The system of claim 21, wherein said system is capable of forming an electric field gradient along said tubular housing to promote growth of a nerve fiber towards a damaged or cut end.

40. The system of claim 21, wherein said integrated circuits comprise a wired or wireless connection to said external microcomputer and said external power source.

41. The system of claim 23, wherein said microcontroller controls the voltages switched onto said integrated electrode tracks of said flexible substrate.

42. The system of claim 23, wherein said microcontroller is integrated with a transistor array into at least one of said integrated circuits.

43. The system of claim 21, wherein said power source comprises a battery.

44. The system of claim 21, wherein said power source is connected to said one or more integrated circuits using a wired or wireless connection.

45. The system of claim 21, wherein said microcomputer has communication means with said one or more integrated circuits.

46. The system of claim 21, wherein said microcomputer and said microcontroller comprise software and firmware that controls the activation of said integrated transistor array.

47. A method for promoting nerve regeneration in a mammal having an injured nerve, wherein said method comprises:

(a) obtaining a system comprising;

(i) a housing comprising a distal end, a proximal end, and a plurality of segments from said distal end to said proximal end, wherein said housing defines a cavity region for nerve regeneration, and wherein each of said plurality of segments comprises an electrode;

(ii) an integrated circuit configured to control at least one of said electrodes;

(iii) a pump configured to release an agent into said cavity region; and

(iv) a power supply configured to provide power to said integrated circuit, said at least one of said electrodes, or said pump; and

(b) placing an end of said injured nerve into or proximal to said distal end of said housing.

48. The method of claim 47, wherein said method comprises exposing said injured nerve to said agent and electricity from said electrode.

49. The method of claim 47, wherein said agent is a nerve growth factor.